Erythropoietin as a Pharmacologic Alternative to Blood Transfusion in the Surgical Patient
- 31 October 1990
- journal article
- review article
- Published by Elsevier in Transfusion Medicine Reviews
- Vol. 4 (4) , 288-296
- https://doi.org/10.1016/s0887-7963(90)70271-4
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- A Trial of Desmopressin (1-Desamino-8-D-Arginine Vasopressin) to Reduce Blood Loss in Uncomplicated Cardiac SurgeryNew England Journal of Medicine, 1989
- Increased Preoperative Collection of Autologous Blood with Recombinant Human Erythropoietin TherapyNew England Journal of Medicine, 1989
- Treatment of the Anemia of Progressive Renal Failure with Recombinant Human ErythropoietinNew England Journal of Medicine, 1989
- ErythropoietinTransfusion, 1989
- Twenty Years of Coronary Bypass SurgeryNew England Journal of Medicine, 1988
- The Patient's Blood is the Safest BloodNew England Journal of Medicine, 1987
- Predeposited Autologous Blood for Elective SurgeryNew England Journal of Medicine, 1987
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- Fluosol-DA as a Red-Cell Substitute in Acute AnemiaNew England Journal of Medicine, 1986
- Treatment with Desmopressin Acetate to Reduce Blood Loss after Cardiac SurgeryNew England Journal of Medicine, 1986